Five Prime Therapeutics Inc
CD80 EXTRACELLULAR DOMAIN FC FUSION PROTEIN DOSING REGIMENS

Abstract:

The present disclosure provides methods of administering fusion proteins comprising the extracellular domain of human cluster of differentiation 80 (CD80) and the fragment crystallizable (Fc) domain of human immunoglobulin G 1 (IgG1) to a subject in need thereof, for example, a cancer patient.